Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$78.97

0.435 (0.55%)

10:33
10/18/16
10/18
10:33
10/18/16
10:33

Eli Lilly announces $90M investment in Lilly Global Health Partnership

Eli Lilly announced a plan to increase access to quality health care and to improve long-term health for millions of people worldwide, with an aim to reach 30 million people in resource-limited settings annually by 2030. The cornerstone of this goal - known as "Lilly 30x30" - is a new five-year, $90M investment in the Lilly Global Health Partnership, which will improve access to treatment for diabetes, cancer and tuberculosis. One-half of the $90M commitment will come from the Eli Lilly and Company Foundation; the other half will come from company funds. The $90M investment will accelerate the company's and the Foundation's global health work with key international, national and local partners. The Lilly Global Health Partnership will expand current work in diabetes and TB and add cancer as a new therapeutic area of focus. To reach 30M people annually in communities with limited resources - a six-fold increase over the number reached today - Lilly will explore new approaches within different areas of its business, the company added.

  • 25

    Oct

  • 06

    Nov

LLY Eli Lilly
$78.97

0.435 (0.55%)

10/13/16
JEFF
10/13/16
DOWNGRADE
Target $36
JEFF
Hold
Pfizer downgraded to Hold from Buy at Jefferies
Jefferies analyst Jeffrey Holford downgraded Pfizer (PFE) to Hold citing a lack of positive catalysts. The analyst says the drivers for his upgrade to Buy have either played out or have not materialized, namely an inversion or GEP unit separation. To reflect the infusion business disposal and weaker Ibrance trends, Holford cut his mid-term earnings estimates for Pfizer by up to 7% and cut his price target for the shares to $36 from $39. The stock closed yesterday down 6c to $33.07. The analyst also sees increased risk of a major acquisition occurring over the next 12 months. In the global pharma space, Holford lists AbbVie (ABBV), Eli Lilly (LLY), Novartis (NVS) and AstraZeneca (AZN) as his top picks.
09/28/16
BERN
09/28/16
NO CHANGE
BERN
Biogen likely to benefit from Lilly Alzheimer's drug results, says Bernstein
Bernstein analyst Aaron Gal says that the results of a trial of Eli Lilly's (LLY) Alzheimer's drug, solanezumab, due out in late 2016 or early 2017, are likely to impact perceptions of Biogen's (BIIB) Alzheimer's drug, aducanumab. The analyst expects Lilly's solanezumab "to show at least directional evidence" of cognitive improvement, although he is "less convinced" that the impact will be clearly statistically significant. The best results from Biogen's perspective will be if Lilly's drug shows "marginal success," according to Gal. However, statistically significant results are also good for Biogen, as they will show that reducing amyloid beta does mitigate Alzheimer's symptoms, the analyst stated. And if Lilly's drug completely fails, Biogen's drug "could well succeed," given the significant differences between them, wrote Gal,who gives Biogen's aducanumab a 65% chance of success. He keeps a $345 price target and Outperform rating on Biogen.
09/27/16
09/27/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Eli Lilly (LLY) upgraded to Buy from Neutral at Goldman with analyst Jami Rubin saying the company is entering a long lasting period of accelerating topline and earnings growth driven by its late stage pipeline. 2. AutoZone (AZO) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman saying the company is at a positive inflection in 7 year and older vehicles, which is strongly correlated to same-store-sales. 3. Consolidated Edison (ED) upgraded to Hold from Sell at Evercore ISI with analyst Greg Gordon saying the joint settlement proposal filed in the CECONY rate case mitigates downside risk. 4. Crown Holdings (CCK) upgraded on multiple catalysts at BMO Capital with analyst Mark Wilde citing valuation, his belief that the company will resume returning cash to shareholders in 2017, and his belief that the company's results should be boosted by " a wave of domestic and offshore expansion projects." 5. Francesca's (FRAN) upgraded to Buy from Hold at Stifel with analyst Richard Jaffe saying the company's "appealing merchandise" makes it very likely that its sales will grow going forward. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/27/16
GSCO
09/27/16
UPGRADE
Target $95
GSCO
Buy
Eli Lilly upgraded to Buy from Neutral at Goldman
Goldman analyst Jami Rubin upgraded Eli Lilly to Buy and increased its price target to $95 from $89 saying the company is entering a long lasting period of accelerating topline and earnings growth driven by its late stage pipeline. Rubin projects $12.5B of new product sales by 2020 and double digit earnings growth over the next five years, even without Sola. The analyst sees a 35%, up from 25%, probability of success for Sola with a bull case scenario that can lead to almost $7.5B in peak sales and "super charge" earnings. Even without Sola, Rubin sees favorable risk/reward given durability of earnings and said it is the least exposed to above-CPI price increases.

TODAY'S FREE FLY STORIES

T

AT&T

$39.69

-0.22 (-0.55%)

13:52
04/28/17
04/28
13:52
04/28/17
13:52
Hot Stocks
AT&T invested nearly $7.2B in California wireless and wired networks »

AT&T invested nearly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

  • 16

    May

  • 17

    May

LL

Lumber Liquidators

$24.50

0.14 (0.57%)

13:51
04/28/17
04/28
13:51
04/28/17
13:51
Options
Bullish earnings play in Lumber Liquidators »

Bullish earnings play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

QCOM

Qualcomm

$53.21

0.17 (0.32%)

, AAPL

Apple

$143.79

0.11 (0.08%)

13:50
04/28/17
04/28
13:50
04/28/17
13:50
Recommendations
Qualcomm, Apple analyst commentary  »

Oppenheimer doesn't…

QCOM

Qualcomm

$53.21

0.17 (0.32%)

AAPL

Apple

$143.79

0.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 08

    May

SPY

SPDR S&P 500 ETF Trust

$238.16

-0.44 (-0.18%)

, IVV

iShares Core S&P 500

$239.68

-0.41 (-0.17%)

13:46
04/28/17
04/28
13:46
04/28/17
13:46
Technical Analysis
On The Fly: ETF fund flow highlights »

Per data from ETF.com,…

SPY

SPDR S&P 500 ETF Trust

$238.16

-0.44 (-0.18%)

IVV

iShares Core S&P 500

$239.68

-0.41 (-0.17%)

VOO

Vanguard S&P 500 ETF

$218.65

-0.37 (-0.17%)

IWM

iShares Trust Russell 2000 Index Fund

$139.61

-1.34 (-0.95%)

QQQ

PowerShares QQQ Trust

$135.75

0.81 (0.60%)

XLF

Financial Select Sector

$23.62

-0.145 (-0.61%)

IEMG

iShares Core MSCI Emerging Markets

$48.67

0.065 (0.13%)

EZU

iShares MSCI Eurozone ETF

$39.33

0.0493 (0.13%)

TLT

iShares 20+ Year Treasury Bond Fund

$122.08

-0.04 (-0.03%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$88.16

0.01 (0.01%)

XLP

Consumer Staples Sector SPDR

$55.11

-0.09 (-0.16%)

VNQ

Vanguard REIT Index Fund

$82.86

-0.8037 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPN

Calpine

$10.00

0.41 (4.28%)

13:31
04/28/17
04/28
13:31
04/28/17
13:31
Options
Calpine calls active after earnings »

Calpine calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:30
04/28/17
04/28
13:30
04/28/17
13:30
General news
NY Fed accepted $181.98 B in daily reverse repos »

NY Fed accepted $181.98 B…

ALDR

Alder Biopharmaceuticals

$21.35

-0.8 (-3.61%)

13:25
04/28/17
04/28
13:25
04/28/17
13:25
Hot Stocks
Alder Biopharmaceuticals presents 'positive' Phase 2b data for Eptinezumab »

Alder BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

OCN

Ocwen

$2.26

0.03 (1.35%)

13:22
04/28/17
04/28
13:22
04/28/17
13:22
Periodicals
CFPB was seeking Ocwen settlement in $50M range, IMF reports »

The Consumer Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 24

    May

BCEI

Bonanza Creek

$0.79

0.0099 (1.27%)

13:21
04/28/17
04/28
13:21
04/28/17
13:21
Hot Stocks
Breaking Hot Stocks news story on Bonanza Creek »

Bonanza Creek trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:17
04/28/17
04/28
13:17
04/28/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
04/28/17
04/28
13:16
04/28/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAN

Banco Santander

$6.53

0.08 (1.24%)

13:16
04/28/17
04/28
13:16
04/28/17
13:16
Options
Banco Santander put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
04/28/17
04/28
13:15
04/28/17
13:15
General news
Energy Action: Baker-Hughes »

Energy Action:…

BCEI

Bonanza Creek

$0.79

0.0099 (1.27%)

13:10
04/28/17
04/28
13:10
04/28/17
13:10
Hot Stocks
Bonanza Creek announces emergence from Chapter 11 bankruptcy »

Bonanza Creek Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:06
04/28/17
04/28
13:06
04/28/17
13:06
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 4/28 Baker-Hughes…

MSI

Motorola Solutions

$85.88

-0.19 (-0.22%)

13:04
04/28/17
04/28
13:04
04/28/17
13:04
Hot Stocks
Motorola Solutions: ITC to probe unfair trade practices by Hytera »

Motorola Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 31

    May

BCEI

Bonanza Creek

$0.79

0.0049 (0.63%)

13:03
04/28/17
04/28
13:03
04/28/17
13:03
Hot Stocks
Breaking Hot Stocks news story on Bonanza Creek »

Bonanza Creek trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHI

Baker Hughes

$59.34

-0.31 (-0.52%)

13:03
04/28/17
04/28
13:03
04/28/17
13:03
Hot Stocks
Baker Hughes reports U.S. rig count up 13 to 870 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBP

Huttig Building Products

$9.03

0.28 (3.20%)

13:01
04/28/17
04/28
13:01
04/28/17
13:01
Hot Stocks
Huttig Building announces national distribution pact with Knauf Insulation »

Huttig Building Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

13:00
04/28/17
04/28
13:00
04/28/17
13:00
General news
Breaking General news story  »

Federal Reserve Board of…

HNHPF

Hon Hai Precision

12:59
04/28/17
04/28
12:59
04/28/17
12:59
Periodicals
Foxconn to invest in U.S., Reuters reports »

Terry Gou, chairman of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEF

iShares 7-10 Year Treasury Bond ETF

$106.48

-0.015 (-0.01%)

12:51
04/28/17
04/28
12:51
04/28/17
12:51
Options
$7.7M vote of confidence in iShares 7 to 10 year Treasury Bond ETF »

$7.7M vote of confidence…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPN

Calpine

$9.95

0.3599 (3.75%)

12:48
04/28/17
04/28
12:48
04/28/17
12:48
Periodicals
Calpine viewed as potential leveraged buyout target, SparkSpread says »

Comments from Calpine CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
04/28/17
04/28
12:45
04/28/17
12:45
General news
Breaking General news story  »

Week of 4/28 Baker-Hughes…

CMCSA

Comcast

$39.59

0.8 (2.06%)

, CMCSK

Comcast

12:40
04/28/17
04/28
12:40
04/28/17
12:40
Hot Stocks
Box Office Battle: 'Fate of the Furious' still leading competition »

Coming back for its third…

CMCSA

Comcast

$39.59

0.8 (2.06%)

CMCSK

Comcast

FOXA

21st Century Fox

$30.56

-0.18 (-0.59%)

LGF.B

Lionsgate

$23.85

-0.15 (-0.63%)

DIS

Disney

$115.42

-0.4199 (-0.36%)

VIAB

Viacom

$43.31

-0.07 (-0.16%)

LGF.A

Lionsgate

$26.15

-0.13 (-0.49%)

VIA

Viacom

$45.40

0.4 (0.89%)

SNE

Sony

$34.26

0.535 (1.59%)

FOX

21st Century Fox

$29.93

-0.12 (-0.40%)

TWX

Time Warner

$99.56

-0.34 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 04

    May

  • 08

    May

  • 10

    May

  • 24

    May

  • 25

    May

  • 15

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.